MLTX MoonLake Immunotherapeutics

• None no insider bought on the open market
• $65.7M sold by 2 insiders outside a trading plan
• $9.7M sold by 3 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Kristian Reich Chief Scientific Officer
   Planned sale
   $22K 1,100 shares at $20.00 <0.1% of stake
   Traded Jul 27 Filed Jul 29
   ↗
3. Kristian Reich Chief Scientific Officer
   Planned sale
   $1M 52,448 shares at $20.02 1.9% of stake
   Traded Jul 21–22 Filed Jul 23
   ↗
4. Kristian Reich Chief Scientific Officer
   Planned sale
   $878K 43,700 shares at $20.09 1.6% of stake
   Traded Jul 20 Filed Jul 21
   ↗
5. Kristian Reich Chief Scientific Officer
   Planned sale
   $322K 16,105 shares at $20.01 0.6% of stake
   Traded Jul 15 Filed Jul 20
   ↗
6. Da Silva Jorge Santos CEO
   Planned sale
   $2M 102,225 shares at $20.02 3.6% of stake
   Traded Jul 9–10 Filed Jul 13
   ↗
7. Da Silva Jorge Santos CEO
   Planned sale
   $957K 47,775 shares at $20.03 1.6% of stake
   Traded Jul 1 Filed Jul 2
   ↗
8. Matthias Bodenstedt CFO
   Planned sale
   $862K 39,120 shares at $22.04 3.4% of stake
   Traded Jun 22 Filed Jun 23
   ↗
9. Matthias Bodenstedt CFO
   Planned sale
   $352K 17,876 shares at $19.67 1.5% of stake
   Traded Jun 17–18 Filed Jun 18
   ↗
10. Kristian Reich Chief Scientific Officer
    Planned sale
    $2.9M 150,000 shares at $19.01 5% of stake
    Traded Jun 15–17 Filed Jun 17
    ↗
11. Matthias Bodenstedt CFO
    Planned sale
    $273K 13,653 shares at $20.02 1.2% of stake
    Traded May 11 Filed May 13
    ↗
12. Matthias Bodenstedt CFO
    Planned sale
    $47K 2,426 shares at $19.56 0.2% of stake
    Traded Apr 14 Filed Apr 16
    ↗
13. Da Silva Jorge Santos CEO
    Sale
    $2.8M 150,000 shares at $18.35 4.9% of stake
    Traded Apr 10–13 Filed Apr 14
    ↗
14. Bvf Partners L P Director, +9 joint filers
    Sale
    $63M 3,750,000 shares at $16.79 78% of stake
    Traded Mar 31 Filed Apr 2
    ↗
15. Matthias Bodenstedt CFO
    Buy
    $99K 10,870 shares at $9.09 +1.8% to stake
    Traded Oct 8, 2025 Filed Oct 9, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 6 sales to cover taxes, 3 conversions, 3 sales back to the company, and 1 stock grant.